Testing the Feasibility of a Guided Imagery Tobacco Cessation Intervention Delivered by a Telephone Quitline: Study Protocol for a Randomized Controlled Feasibility Trial
Overview
Affiliations
Background: Guided imagery (GI) is an evidence-based method that uses the imagination to practice and achieve a desired outcome. Little research has focused on how GI can be delivered to smokers using remote or virtual methods, such as a telephone-based intervention. Telephone-based services for tobacco cessation (quitlines) have emerged as standard of care for tobacco cessation. However, quitlines reach only a small fraction of smokers, and men and racial/ethnic minorities are less likely to use quitlines than majority women. GI has the potential to attract under-served minority groups as well as smokers who are looking for an alternative approach to cessation. The present study is designed to test the feasibility and potential impact of a GI tobacco cessation intervention delivered by telephone. This study compares the GI intervention with a standard behavioral (SB) intervention.
Methods: Participants (N = 100) are randomized to either the GI (intervention) or SB (control) condition. Each condition features a 6-week intervention in which participants work with coaches to quit tobacco. Primary outcomes are feasibility related (recruitment, retention, adherence), and secondary outcomes include cessation at 6 months post-intervention (7-day and 30-day abstinence).
Discussion: A GI intervention delivered via quitline would allow for scalability and dissemination, potentially reaching a more representative group of smokers. Results from this study will determine the feasibility of delivering the GI intervention, and describe the reach of the intervention to under-represented tobacco users. If successful, our study results will guide the design and conduct of a future efficacy trial.
Predictors of Enrollment and Adherence in a Randomized Tobacco Cessation Clinical Trial.
Coffee Z, Hsu C, Vanderah T, Gordon J Tob Use Insights. 2024; 17:1179173X241308136.
PMID: 39678308 PMC: 11638983. DOI: 10.1177/1179173X241308136.
Gordon J, Armin J, Giacobbi Jr P, Hsu C, Marano K, Sheffer C JMIR Res Protoc. 2023; 12:e48898.
PMID: 37351932 PMC: 10337344. DOI: 10.2196/48898.
Armin J, Nair U, Giacobbi P, Povis G, Barraza Y, Gordon J Tob Use Insights. 2020; 13:1179173X20949267.
PMID: 32922107 PMC: 7446272. DOI: 10.1177/1179173X20949267.
Gordon J, Bell M, Armin J, Giacobbi P, Nair U Transl Behav Med. 2020; 11(2):516-529.
PMID: 32542352 PMC: 7963280. DOI: 10.1093/tbm/ibaa052.